Takeda | pharmaphorum

Sunday 20 September 2026

Takeda

News

Takeda proposes selling Shire’s IBD treatment after merger

Takeda proposes selling Shire’s IBD treatment after merger

Takeda has proposed selling off a Shire treatment for inflammatory bowel disease when the companies merge next year, to avoid an overlap with its own drug.

News

Bruce T. Martin Photography
508-655-7557
btm@brucetmartin.com
154 East Central St
Natick MA 01760

FDA advisers back Shire constipation drug

Shire’s constipation drug prucalopride is moving closer to market – advisers to the FDA have just unanimously backed it as a treatment for chronic idiopathic constipation (CIC) in adults.

News

Takeda could sell Shire eye care business after merger

Takeda could sell Shire eye care business after merger

Takeda could be considering selling Shire’s eye care business after their $62 billion merger next year to cut debts, according to press reports.

News

Shire HQ

Shire buys Swiss plasma collection company sanaplasma

Shire has bought sanaplasma, a plasma collection company headquartered in Switzerland.

News

Samsung Bioepis HQ

Samsung Bioepis and Takeda begin first trial from R&D tie-up

Companies signed risk-sharing deal last year

News

Asit Parikh

Takeda finalises buyout of TiGenix

Japanese pharma giant Takeda has completed its buyout of TiGenix.